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Abstract
Background: Current epidemiological data on the situation of Coxiella (C.) burnetii infections in sheep are missing,
making risk assessment and the implementation of counteractive measures difficult. Using the German state of
Thuringia as a model example, the estimated sero-, and antigen prevalence of C. burnetii (10% and 25%,
respectively) was assessed at flock level in 39/252 randomly selected clinically healthy sheep flocks with more than
100 ewes and unknown abortion rate.
Results: The CHECKIT™ Q-fever Test Kit identified 11 (28%) antibody positive herds, whereas real-time PCR
revealed the presence of C. burnetii DNA in 2 (5%) of the flocks. Multiple-locus variable number of tandem repeats
analysis of 9 isolates obtained from one flock revealed identical profiles. All isolates contained the plasmid QpH1.
Conclusions: The results demonstrate that C. burnetii is present in clinically inconspicuous sheep flocks and
sporadic flare-ups do occur as the notifications to the German animal disease reporting system show. Although C.
burnetii infections are not a primary veterinary concern due to the lack of significant clinical impact on animal
health (with the exception of goats), the eminent zoonotic risk for humans should not be underestimated.
Therefore, strategies combining the interests of public and veterinary public health should include monitoring of
flocks, the identification and culling of shedders as well as the administration of protective vaccines.
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Background
C. burnetii is an obligate intracellular bacterial pathogen
and the causative agent of Q- fever, a worldwide occur-
ring zoonosis, and notifiable disease in many countries
including Germany. The organism is very resistant and
can persist in the environment in a spore-like state for
weeks; once airborne it can be transported long dis-
tances by the wind [1-3]. Numerous species including
dogs, cats, birds, arthropods, and wildlife can harbour
the agent, however, cattle, sheep, and goats are consid-
ered to be the main reservoir [4]. Infection in animals is
mostly subclinical or inapparent but can occasionally
lead to abortions or birth of weak offspring. During par-
turition, large numbers of the organism are shed into
the birth fluids, but smaller amounts can also be found
in milk, faeces, and urine [5]. Transmission to humans
occurs mainly via inhalation of fomites, seldom through
ingestion of contaminated raw milk, and very rarely via
person-to-person contact [4]. In humans, disease ranges
from asymptomatic to severe and can be fatal. The clini-
cal picture presents itself with fever or influenza-like ill-
ness. Pneumonia, hepatitis, meningoencephalitis,
myocarditis, and pericarditis can occur as life-threaten-
ing complications. Infection in early pregnancy can lead
to abortion and in later stages of pregnancy to prema-
ture labour [6].
According to the Federal Statistical Office, there are
approx. 2.35 million sheep in Germany. Despite the gra-
dual decline in the German sheep population and falls
in the price of wool over the past years, foodstuffs
obtained from sheep (i.e. meat and milk) are enjoying
an increase in popularity. In the state of Thuringia, the
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only as a source of meat and milk, but also plays an
important role in landscape management and nature
conservation. The sheep are distributed among approx.
6300 flocks of which 252 contain more than 100 ewes.
Although several German studies describing the sero-
prevalence of C. burnetii in sheep during outbreaks of
Q-fever exist [7-9], no current prevalence data are avail-
able. Moreover, seroprevalence studies in asymptomatic,
i.e. clinically healthy flocks, and in flocks with prevailing
infections are missing, making risk assessment and the
implementation of counteractive measures and regula-
tions difficult.
Accordingly, the aim of this study was to estimate the
sero- and antigen prevalence of C. burnetii at flock level
among clinically healthy non-vaccinated sheep flocks
using the state of Thuringia as a model example.
Results
Serology
Based on the sensitivity and specificity of the used test
of 100% a flock was considered sero-positive if at least
one animal tested positive in the ELISA. Of the 39 eval-
uated flocks with more than 100 ewes, 11 were serologi-
cally positive (28%; Table 1). The exact 95% confidence
interval for the flock-level prevalence was estimated as
15-45%.
Isolation of C. burnetii
C. burnetii was isolated and propagated from nine after-
births acquired from flock 13. Three of these isolates
were obtained from samples collected during the preva-
l e n c es t u d yi nM a y2 0 0 9( T a b l e1 ) ,o n ei s o l a t ew a s
obtained from a sample collected before initiation of the
study, and the remaining five isolates originated from
additional samples collected in June 2009 (Table 2).
Detection of C. burnetii by means of PCR
Based on the specificity and sensitivity of the PCR assay
of 100% a flock was considered antigen-positive if at
least one animal tested positive in the PCR. C. burnetii
DNA was detected in two flocks (5%; Table 1). The
exact 95% confidence interval for the flock-level preva-
lence was estimated as 0.6-17%.
Genotyping of C. burnetii by means of MLVA and plasmid
type determination
In order to investigate the genetic relationship among
the isolates obtained from afterbirths collected in flock
13, MLVA were done. These revealed identical VNTR
profiles all clustering into the same group (Figure 1). All
tested isolates were shown to contain the plasmid
QpH1.
Discussion
Epidemiological data regarding the distribution of C.
burnetii in sheep in Germany are scarce and based on
data obtained during Q-fever outbreaks [7,8] and on
materials submitted for routine laboratory examination
[9]. Data describing the epidemiological situation in
clinically inconspicuous flocks and between outbreaks
are missing. The present study, therefore, aimed at esti-
mating the sero- and antigen prevalence of C. burnetii
in randomly chosen non-vaccinated sheep flocks
throughout the state of Thuringia with unknown abor-
tion status.
Our study revealed that 28% of the tested flocks were
serologically positive. Other studies assessing the sero-
prevalence of C. burnetii in sheep found rates ranging
between 1% to 47% in Germany [8-10], 3% to 22% in
Turkey [11,12], 12% in northern Spain and 31.7% in
Gran Canaria [13,14], 11.8% in southern Italy [15], and
up to 73% in Bulgaria [16]. However, the direct compar-
ison of our results with the prevalences found in the
above listed studies is problematic, due to considerable
differences in study design and evaluation methods (pre-
valence in single animals vs. flock prevalence), flock size,
flock management, abortion rate, number of samples
tested and the detection methods applied (CFT, IFAT,
competitive ELISA).
We next compared our data with the results obtained
from the ovine samples (> 1500) submitted to the Ger-
man National Reference Laboratory (NRL) for Q-fever.
Evaluation of the samples sent to the NRL between
August 2007 and July 2010 determined a seroprevalence
of 10.8%, which is in agreement with our estimated pre-
valence value; yet one has to bear in mind that the eva-
luation of these samples is biased. We also compared
our results with those acquired from the contempora-
neous Thuringian Brucella screening in which the ovine
samples were additionally tested for the presence of C.
burnetii antibodies with the CHEKIT™ Q-fever Test
Kit. The screening revealed a seroprevalence of 31% (4/
13 flocks) when evaluating the results from the flocks
w i t h>1 0 0e w e sw h i c hi sa l s oi na g r e e m e n tw i t ho u r
results (data not shown). We can not rule out a possible
lower sensitivity of the used ELISA due to the fact that
it does not use ruminant antigen. However, this particu-
lar ELISA is the only one on the “List of certified pro-
ducts pursuant to section 17c Animal Diseases Act” in
Germany. Moreover, even if we had found more positive
animals within a flock, it would not have had an influ-
ence on the flock prevalence. Further positive flocks on
the other hand, would have altered the flock prevalence.
Despite the fact that serological screening to test for
antibodies against C. burnetii is carried out on a regular
basis, results should be interpreted with caution. Recent
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tle, sheep and goats showed that shedding animals are
not always reliably detected; single animals may sero-
convert but not shed the agent, whereas others shed the
agent without or with delayed production of antibodies
[17-19]. One also has to bear in mind that antibodies
may continue to circulate long after the agent has been
cleared from the organism [20].
Our PCR analyses detected C. burnetii DNA in 5% of
the flocks assessed in the study. Recent PCR-based
Table 1 Summary of flocks, collected -, positive serum-, and DNA (PCR positive) samples
# positive samples vs. # of samples taken
flock
#
flock size
(ewes)
abortion rate
(%)
§
serum vaginal swab rectal swab afterbirth foetus/foetal swab
1 500 0 1/28 0/11 0/11 0/11 - -
2 1000 0 0/29 0/11 0/11 0/11 0/9 -
3 1800 < 1 4/29 2/11 0/11 0/11 0/11 -
4 1300 0 0/29 0/11 0/11 0/11 - -
5 1200 3 4/29 3/11 0/11 0/11 0/3 0/4
6 500 0 0/29 0/11 0/11 0/11 - -
7 450 0 0/29 0/11 0/11 0/11 0/9 -
8 1100 < 1 3/30 1/11 0/11 0/11 - -
9 1800 0 1/29 0/11 0/11 0/11 - -
10 550 0 4/29 2/11 0/11 0/11 0/3 -
11 700 < 1 2/29 2/11 0/11 0/11 - -
12 330 0 0/30 0/11 0/11 0/11 0/2 -
13* 2500 2 6/30 1/11 11/11 11/11 7/11** -
14 400 < 1 0/29 0/11 0/11 0/11 - -
15 700 < 1 0/29 0/11 0/11 0/11 - -
16 750 < 1 0/29 0/11 0/11 0/11 - -
17 900 < 1 0/29 0/11 0/11 0/11 0/3 0/2
18 250 < 1 0/29 0/11 0/11 0/11 - -
19 450 < 1 0/29 0/11 0/11 0/11 0/1 -
20 1000 < 1 0/29 0/11 0/11 0/11 - -
21 500 < 1 0/29 0/11 0/11 0/11 - -
22 406 < 1 0/29 0/11 0/11 0/11 - -
23 700 < 1 3/29 2/11 0/11 0/11 - -
24 700 0 0/29 0/11 0/11 0/11 - -
25 550 < 1 5/29 1/11 0/11 0/11 - -
26 1000 1 0/29 0/11 0/11 0/11 - -
27 317 < 1 0/29 0/11 0/11 0/11 - -
28 350 6 0/29 0/11 0/11 0/11 0/1 -
29 420 0 0/29 0/11 0/11 0/11 - -
30 1178 < 1 0/29 0/11 0/11 0/11 - -
31 500 < 1 0/29 0/11 0/11 0/11 - -
32 120 0 0/29 0/11 0/11 0/11 0/4 -
33 115 < 1 17/29 6/11 1/11 1/11 --
34 400 < 1 0/29 0/11 0/11 0/11 0/1 -
35 650 < 1 0/29 0/11 0/11 0/11 - -
36 133 0 0/29 0/11 0/11 0/11 - -
37 377 < 1 0/29 0/11 0/11 0/11 0/2 -
38 409 < 1 0/29 0/11 0/11 0/11 - -
39
& 25 0 25 11 11 - -
40 460 < 1 0/29 0/11 0/11 0/11 - -
total 1158 440 440 71 6
§according to farmers and Thuringian sheep health authority; *history of C. burnetii infection; **7/11 DNA positive, from 3/7 isolation of C. burnetii; - no samples;
&excluded from study
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in northern Spain [21] and in 18.6% of farms with small
ruminants in southern Italy [22]. Two further studies on
samples obtained from either ovine abortions in Sardinia
[23] or ovine foetal organ samples and placentae in Por-
tugal [24] discovered C. burnetii in 10.9% and in 36% of
the cases, respectively. A Turkish study assessing milk
samples collected from 22 flocks determined 6.5% C.
burnetii positive animals in 12 flocks with a history of
abortion and no positives in flocks without a history of
abortion [25]. But again, comparison of the data is diffi-
cult due to the differences in study design, sampling,
and methods applied. However, the evaluation of the C.
burnetii-tested samples of the contemporaneous Thurin-
gian Brucella screening using different sampling criteria,
e.g. health status, flock size, etc. revealed an antigen
prevalence of 25%, which is in agreement with our esti-
mated prevalence.
Although we found eleven seropositive flocks, only
two of the flocks (13, 33) were DNA-positive. Nonethe-
l e s s ,w ew e r ea b l et oo b t a i nn i n ei s o l a t e sf r o mf l o c k1 3
in afterbirths collected between April 2008 and June
2009. All isolates were genetically identical as shown by
MLVA and determination of the plasmid type. The
QpH1 plasmid, first isolated from a tick [26], has been
regularly found in isolates obtained from cattle, sheep,
and goats [27]. We were intrigued to find that our nine
isolates clustered into the same group as the isolates
obtained from sheep and a human isolate linked to a Q-
fever outbreak back in 2003 in North Rhine Westphalia
[28]. Our findings argue for the circulation of a particu-
lar C. burnetii strain infecting both man and animal in
central Germany, however, more isolates must be tested
to corroborate this hypothesis. We did not observe any
genetic variations as described in the exceptional Dutch
outbreak (2007-2010) [29,30] in our comparatively small
panel, although we used more loci and purified DNA
from isolates. It is worthwhile mentioning that C. burne-
tii was already detected back in 2005 in flock 13, indi-
cating the persistence of infection in this flock.
However, since no isolates were obtained in 2005 we
can not confirm the circulation of one particular strain
or exclude re-introduction.
Identification of shedders is central to any eradication
or surveillance programme. We believe that monitoring
of clinically inconspicuous sheep flocks for the presence
of C. burnetii infection can be reliably done by analysing
the afterbirths. As shown in Table 2, in January 2008,
none of the examined afterbirths reacted positive in the
PCR assays but by June 2009, 75% of the tested
Table 2 Additional samples collected in flocks 3, 13 and 33 (analysed by ELISA or PCR)
# positive samples vs. # of samples taken
flock
#
date
flock size
(ewes)
abortion
rate
(%)
serum vaginal swab rectal swab afterbirth foetus/foetal swab
3 (01/2010) 1800 < 1 1/34 0/11 0/11 0/5 0/8
13
(07/2005) - - 1/51 - - -
(12/2005) - - - - - 1/14
(01/2008) 2500 - - - - 0/18 -
(04/2008) 2 - - - 2/34* -
(05/2009) - 1/6 - - 8/19* 0/1
(06/2009) - - - - 18/24* -
(07/2010) - - - - 0/58 -
(03/2011) - - 0/107 - - -
33
(02/2010) 115 < 1 42/89 5/26 - - -
(07/2010) - - - - 0/11 -
- no samples; *1/34 C. burnetii isolate; *1/19 C. burnetii isolate; *4/24 C. burnetii isolates
Figure 1 Phylogenetic tree of German C. burnetii isolates on
the basis of 17 multilocus variable number of tandem repeat
analyses (MLVA).
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births and vaginal swabs taken between July 2010 and
March 2011 were again negative. Our observations are
in agreement with the findings of others, describing that
shedding is not a continuous process [31,32]. However,
it is also possible that the amounts of shed or circulating
bacteria might not suffice to maintain an infection cycle.
The threshold level of bacteria required to produce a
clinically apparent infection in an animal and to what
extent virulence of the circulating strain affects infection
and clinical presentation are still unknown. Studies
assessing possible individual or breed related immunity
are also missing.
Conclusions
Based on the assumed prevalence at flock level, we were
able to demonstrate that C. burnetii is present in clini-
cally inconspicuous sheep flocks. Although C. burnetii
infections are not a primary veterinary concern, due to
the lack of significant impact on animal health, the zoo-
notic risk for humans should not be underestimated.
Therefore, strategies combining the interests of public
and veterinary public health should include the identifi-
cation and culling of shedders as well as the implemen-
tation of protective vaccines.
Materials and methods
Sheep flocks and sampling procedures
The present study was designed as a cross sectional
study. Forty unvaccinated flocks (Table 1) distributed
throughout the state of Thuringia with more than 100
ewes and an unknown abortion rate, were chosen at
random from the given population of 252 flocks. Flocks
were kept on pasture, lambing took place in-doors.
Based on the reported cases to the German animal dis-
ease reporting system, the sample size was calculated as
such that with an assumed minimum seroprevalence of
10% and an antigen prevalence of 25% within the flock,
at least one infected animal would be detected with 95%
confidence under the assumption of 100% sensitivity
and specificity of the diagnostic test used [33].
S e r aa n ds w a b sw e r ec o l l e c t e da tr a n d o md u r i n gt h e
lambing seasons by and under the supervision of a
veterinarian (UM) from the Thuringian sheep health
service during his regular flock management visits
between February 2009 to June 2009 (flocks 1-13) and
December 2009 to April 2010 (flocks 14-40). In practice,
the sampling was carried out as follows: Serum samples
were collected from 29 ewes per flock on day 1 or day 2
post partum. For cultivation and PCR assays, one vagi-
nal and one rectal swab were obtained from 11/29 ewes.
Afterbirths and foetuses were collected when available.
Of the 1281 serum samples, 477 vaginal swabs, 451 rec-
tal swabs, 188 afterbirths and 15 foetuses/foetal/
pharyngeal swabs collected, a total of 1158 serum sam-
ples, 440 vaginal swabs, 440 rectal swabs, 71 afterbirths
and 6 foetuses/foetal swabs from 39 flocks were evalu-
ated (Table 1). Since Coxiella and Chlamydia spp
screening is part of the Thuringian flock management
system no ethics approval and consent was necessary
[34].
Additional samples (not included in the study) were
obtained from flocks 3 (January 2010), 13 (January and
April 2008, May and June 2009, and July 2010) and 33
(July 2010) (Table 2).
Sample preparation and conservation
Blood was drawn from the jugular vein with a 14 gauge
needle into 7.5 mL serum Monovettes (Kabe GmbH,
Nümbrecht-Elsenroth, Germany) and stored upright at
RT for 12 h. The Monovettes were then centrifuged at
1500 ×g for 10 min, the supernatant serum removed
and stored at -20°C until further use. Swabs collected
for nucleic acid extraction were transferred to 200 μL
lysis buffer [(6 M guanidiumisothiocyanate, 10 mM
urea, 20% (v/v) Triton X-100 and 10 mM Tris HCl (pH
4.4))] (Roche Diagnostics, Mannheim, Germany) and
stored at 4°C. Afterbirths and organ samples from
aborted foetuses were stored at -80°C until further use.
ELISA
Serum samples were tested for the presence of antibo-
dies to C. burnetii using the CHECKIT™ Q-fever Test
Kit (Idexx GmbH, Liebefeld-Bern, Switzerland) accord-
ing to the manufacturer’s instructions. All measure-
ments were performed in duplicate. Results were
normalised using the positive and negative control sera
provided in the kit and expressed as percentage of the
positive control according to the following formula:
[(OD sample - OD negative control)/(OD positive con-
trol - OD negative control)] × 100. Sera with values
below 30% were considered negative, sera with values
between 30 and 40% were considered inconclusive, and
sera with values greater 40% were considered as positive.
Cell culture
Propagation and isolation of C. burnetii was performed
using Buffalo Green Monkey (BGM) cells in UltraCul-
ture medium (Bio Whittaker, Walkersville, USA) supple-
mented with 1% non essential amino acids (100×), 1%
vitamins, and 2 mmol L-glutamine (all Biochrom, Berlin,
Germany). Cells were seeded into 25 cm
2 tissue culture
flasks (Greiner Bio-One GmbH, Frickenhausen, Ger-
many) and maintained in a humidified atmosphere with
5% CO2 at 37°C. The cell monolayers were assessed for
confluent growth on the day of inoculation.
Vaginal swabs were rehydrated in 2000 μLo fH a n k ’s
medium, centrifuged at 15 000 ×g for 10 min at RT, and
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ium (Biochrom). Organ samples (approx. 10 g) were
mechanically disrupted, homogenised and resuspended
in 40 mL Hank’s medium. This solution was subse-
quently filtered through 0.45 - 0.2 μm syringe filters
(Minisart, Sartorius, Hannover, Germany). Between 100
μL - 500 μL of the resuspended pellet or the final filtrate
was used for inoculation. After 12-24 h, the medium
was replaced by fresh UltraCulture medium, also used
for further propagation. Cell cultures were monitored
weekly by phase contrast microscopy and propagated
for up to six months. Specimens that showed intracellu-
lar growth of microorganisms were stained according to
the method of Giménez [35]. Cultures were regarded as
positive when small red inclusions containing coccoid
rods were observed.
DNA extraction from samples
DNA from vaginal, rectal, and foetal swabs as well as
from foetal organs was isolated using the High Pure
PCR Template Preparation Kit™ (Roche Diagnostics)
according to the manufacturer’s instructions. Organ
samples were cut into 50 mg sections, mechanically dis-
rupted and digested over night in 200 μL lysis buffer
with 40 μL proteinase K (20 mg/mL) (Roche Diagnos-
tics) at 37°C.
Polymerase chain reaction (PCR)
Conventional PCR
In order to avoid abortive cell cultivation, samples for
cultivation were tested beforehand at the National
Reference Laboratory for Q-fever in Wusterhausen with
a nested PCR method targeting the com 1 gene encod-
ing a 27 kDa outer membrane protein of C. burnetii
[36]. Conventional PCR was carried out in a TC-412
Thermocycler (Techne AG, Burkhardtsdorf, Germany).
From each PCR reaction, 15 μLw e r ea n a l y s e db ya g a r -
ose gel electrophoresis (1.5% w/v in Tris Borate EDTA
buffer).
Real-time PCR
Detection of C. burnetii was performed with a TaqMan
based real-time PCR assay targeting the transposase ele-
ment IS1111 as described by Klee et al. [37] using a
Stratagene Mx3000P Thermocycler (Agilent Technolo-
gies, Santa Clara, CA, USA). Tenfold serial dilution of
cloned IS1111 gene fragments ranging from 1 × 10
0 to
1×1 0
5 plasmid copy numbers were added for Coxiella
DNA quantification and sensitivity control of the assay.
The cycle threshold value (Ct) was calculated by the
instrument’s software MxPro3000P v 4.01. A negative
result was assigned when no amplification occurred or
when the cycle threshold value was ≥ 40.
Identification of the plasmid type in the C. burnetii isolates
Identification of the plasmid type of the isolates was
done according to a modified procedure described by
Zhang et al. [36]. PCR assays were conducted on a Mas-
terCycler ep Thermocycler (Eppendorf, Germany). From
each PCR reaction, 5 μL were analysed by agarose gel
electrophoresis (1.5% w/v in Tris Borate EDTA buffer).
Genotyping of C. burnetii isolates by means of multiple-
loci variable number of tandem repeats analysis (MLVA)
Genotyping of the 9 C. burnetii isolates obtained from
f l o c k1 3w a sd o n ea c c o r d i n gt ot h eV N T Rm e t h o d
described by Arricau-Bouvery et al. [32] using 17 mar-
kers. PCR assays were conducted on a MasterCycler ep
Thermocycler (Eppendorf, Germany). Compatible pri-
mer pairs were subsequently multiplexed and the for-
ward primer for each pair labelled at the 5’-end with a
fluorescent dye (dye set G5, Applied Biosystems). The
PCR products were pooled according to their group and
diluted 1:100 in LiChrosol water (VWR International,
Germany). One μL of this solution was mixed with 13.7
μL Hi-Di formamide and 0.3 μL GeneScan™ 1200 LIZ
Size Standard (both Applied Biosystems) for the repro-
ducible sizing of the fragments, denatured for 3 min at
93°C, and cooled on ice. The PCR products were sepa-
rated in an ABI 3130 Genetic Analyzer (Applied Biosys-
tems) using a 36 cm array and POP7 polymer. Data
obtained from the PeakScanner Ver.1.0 (Applied Biosys-
tems) were analysed with the Bionumerics 6.0 software
package (Applied Maths). The clustering analysis was
based on the categorical coefficient and unweighted pair
group method using arithmetic averages (UGPMA).
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